Short-term supplementation with a specific combination of dietary polyphenols increases energy expenditure and alters substrate metabolism in overweight subjects
Background and Objectives: Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The...
Saved in:
Published in | International Journal of Obesity Vol. 38; no. 5; pp. 698 - 706 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.05.2014
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 0307-0565 1476-5497 1476-5497 |
DOI | 10.1038/ijo.2013.231 |
Cover
Loading…
Abstract | Background and Objectives:
Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The present study investigated the effects of short-term supplementation of two combinations of polyphenols on energy expenditure (EE) and substrate metabolism in overweight subjects.
Subjects and Methods:
Eighteen healthy overweight volunteers (9 women, 9 men; age 35±2.5 years; body mass index 28.9±0.4 kg m
−2
) participated in a randomized, double-blind cross-over trial. Combinations of epigallocatechin-gallate (E, 282 mg day
−1
)+resveratrol (R, 200 mg day
−1
) and E+R+80 mg day
−1
soy isoflavones (S) or placebo capsules (PLA) were supplemented twice daily for a period of 3 days. On day 3, circulating metabolite concentrations, EE and substrate oxidation (using indirect calorimetry) were measured during fasting and postprandial conditions for 6 h (high-fat-mixed meal (2.6 MJ, 61.2 E% fat)).
Results:
Short-term supplementation of E+R increased resting EE (E+R vs PLA: 5.45±0.24 vs 5.23±0.25 kJ min
−1
,
P
=0.039), whereas both E+R (699±18 kJ 120 min
−1
vs 676±20 kJ 120 min
−1
,
P
=0.028) and E+R+S (704±18 kJ 120 min
−1
vs 676±20 kJ 120 min
−1
,
P
=0.014) increased 2–4 h-postprandial EE compared with PLA. Metabolic flexibility, calculated as the postprandial increase to the highest respiratory quotient achieved, tended to be improved by E+R compared with PLA and E+R+S only in men (E+R vs PLA: 0.11±0.02 vs 0.06±0.02,
P
=0.059; E+R+S: 0.03±0.02,
P
=0.009). E+R+S significantly increased fasting plasma free fatty acid (
P
=0.064) and glycerol (
P
=0.021) concentrations compared with PLA.
Conclusions:
We demonstrated for the first time that combined E+R supplementation for 3 days significantly increased fasting and postprandial EE, which was accompanied by improved metabolic flexibility in men but not in women. Addition of soy isoflavones partially reversed these effects possibly due to their higher lipolytic potential. The present findings may imply that long-term supplementation of these dosages of epigallocatechin-gallate combined with resveratrol may improve metabolic health and body weight regulation. |
---|---|
AbstractList | Background and Objectives: Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The present study investigated the effects of short-term supplementation of two combinations of polyphenols on energy expenditure (EE) and substrate metabolism in overweight subjects.Subjects and Methods: Eighteen healthy overweight volunteers (9 women, 9 men; age 35 plus or minus 2.5 years; body mass index 28.9 plus or minus 0.4 kg m super(-2)) participated in a randomized, double-blind cross-over trial. Combinations of epigallocatechin-gallate (E, 282 mg day super(-1))+resve ratrol (R, 200 mg day super(-1)) and E+R+80 mg day super(-1) soy isoflavones (S) or placebo capsules (PLA) were supplemented twice daily for a period of 3 days. On day 3, circulating metabolite concentrations, EE and substrate oxidation (using indirect calorimetry) were measured during fasting and postprandial conditions for 6 h (high-fat-mixed meal (2.6 MJ, 61.2 E% fat)). Results: Short-term supplementation of E+R increased resting EE (E+R vs PLA: 5.45 plus or minus 0.24 vs 5.23 plus or minus 0.25 kJ min super(-1), P=0.039), whereas both E+R (699 plus or minus 18 kJ 120 min super(- 1) vs 676 plus or minus 20 kJ 120 min super(-1 ), P=0.028) and E+R+S (704 plus or minus 18 kJ 120 min super(- 1) vs 676 plus or minus 20 kJ 120 min super(-1 ), P=0.014) increased 2-4 h-postprandial EE compared with PLA. Metabolic flexibility, calculated as the postprandial increase to the highest respiratory quotient achieved, tended to be improved by E+R compared with PLA and E+R+S only in men (E+R vs PLA: 0.11 plus or minus 0.02 vs 0.06 plus or minus 0.02, P=0.059; E+R+S: 0.03 plus or minus 0.02, P=0.009). E+R+S significantly increased fasting plasma free fatty acid (P=0.064) and glycerol (P=0.021) concentrations compared with PLA. Conclusions: We demonstrated for the first time that combined E+R supplementation for 3 days significantly increased fasting and postprandial EE, which was accompanied by improved metabolic flexibility in men but not in women. Addition of soy isoflavones partially reversed these effects possibly due to their higher lipolytic potential. The present findings may imply that long-term supplementation of these dosages of epigallocatechin-gallate combined with resveratrol may improve metabolic health and body weight regulation. BACKGROUND AND OBJECTIVES: Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The present study investigated the effects of short-term supplementation of two combinations of polyphenols on energy expenditure (EE) and substrate metabolism in overweight subjects. SUBJECTS AND METHODS: Eighteen healthy overweight volunteers (9 women, 9 men; age 35 ± 2.5 years; body mass index 28.9 ± 0.4 kg [m.sup.-2]) participated in a randomized, double-blind cross-over trial. Combinations of epigallocatechin-gallate (E, 282 mg[day.sup.-1]) + resveratrol (R, 200 mg[day.sup.-1]) and E + R + 80 mg[day.sup.-1] soy isoflavones (S) or placebo capsules (PLA) were supplemented twice daily for a period of 3 days. On day 3, circulating metabolite concentrations, EE and substrate oxidation (using indirect calorimetry) were measured during fasting and postprandial conditions for 6h (high-fat-mixed meal (2.6 MJ, 61.2 E% fat)). RESULTS: Short-term supplementation of E + R increased resting EE (E + R vs PLA: 5.45 ± 0.24 vs 5.23 ± 0.25 kJ [min.sup.-1], P = 0.039), whereas both E + R (699 ± 18 kJ 120 [min.sup.-1] vs 676 [+ or -] 20 kJ 120 [min.sup.-1], P = 0.028) and E + R + S (704 ± 18 kJ 120 [min.sup.-1] vs 676 ± 20 kJ 120 [min.sup.-1], P = 0.014) increased 2-4 h-postprandial EE compared with PLA. Metabolic flexibility, calculated as the postprandial increase to the highest respiratory quotient achieved, tended to be improved by E + R compared with PLA and E + R + S only in men (E + R vs PLA: 0.11 ± 0.02 vs 0.06± 0.02, P = 0.059; E + R + S: 0.03 [+ or -] 0.02, P = 0.009). E + R + S significantly increased fasting plasma free fatty acid (P = 0.064) and glycerol (P = 0.021) concentrations compared with PLA. CONCLUSIONS: We demonstrated for the first time that combined E + R supplementation for 3 days significantly increased fasting and postprandial EE, which was accompanied by improved metabolic flexibility in men but not in women. Addition of soy isoflavones partially reversed these effects possibly due to their higher lipolytic potential. The present findings may imply that long-term supplementation of these dosages of epigallocatechin -gallate combined with resveratrol may improve metabolic health and body weight regulation. International Journal of Obesity (2014) 38, 698-706; doi:10.1038/ijo.2013.231 Keywords: polyphenols; human substrate metabolism; resveratrol; epigallocatechin-gallate Background and Objectives: Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The present study investigated the effects of short-term supplementation of two combinations of polyphenols on energy expenditure (EE) and substrate metabolism in overweight subjects. Subjects and Methods: Eighteen healthy overweight volunteers (9 women, 9 men; age 35±2.5 years; body mass index 28.9±0.4 kg m −2 ) participated in a randomized, double-blind cross-over trial. Combinations of epigallocatechin-gallate (E, 282 mg day −1 )+resveratrol (R, 200 mg day −1 ) and E+R+80 mg day −1 soy isoflavones (S) or placebo capsules (PLA) were supplemented twice daily for a period of 3 days. On day 3, circulating metabolite concentrations, EE and substrate oxidation (using indirect calorimetry) were measured during fasting and postprandial conditions for 6 h (high-fat-mixed meal (2.6 MJ, 61.2 E% fat)). Results: Short-term supplementation of E+R increased resting EE (E+R vs PLA: 5.45±0.24 vs 5.23±0.25 kJ min −1 , P =0.039), whereas both E+R (699±18 kJ 120 min −1 vs 676±20 kJ 120 min −1 , P =0.028) and E+R+S (704±18 kJ 120 min −1 vs 676±20 kJ 120 min −1 , P =0.014) increased 2–4 h-postprandial EE compared with PLA. Metabolic flexibility, calculated as the postprandial increase to the highest respiratory quotient achieved, tended to be improved by E+R compared with PLA and E+R+S only in men (E+R vs PLA: 0.11±0.02 vs 0.06±0.02, P =0.059; E+R+S: 0.03±0.02, P =0.009). E+R+S significantly increased fasting plasma free fatty acid ( P =0.064) and glycerol ( P =0.021) concentrations compared with PLA. Conclusions: We demonstrated for the first time that combined E+R supplementation for 3 days significantly increased fasting and postprandial EE, which was accompanied by improved metabolic flexibility in men but not in women. Addition of soy isoflavones partially reversed these effects possibly due to their higher lipolytic potential. The present findings may imply that long-term supplementation of these dosages of epigallocatechin-gallate combined with resveratrol may improve metabolic health and body weight regulation. Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The present study investigated the effects of short-term supplementation of two combinations of polyphenols on energy expenditure (EE) and substrate metabolism in overweight subjects. Eighteen healthy overweight volunteers (9 women, 9 men; age 35±2.5 years; body mass index 28.9±0.4 kg m(-2)) participated in a randomized, double-blind cross-over trial. Combinations of epigallocatechin-gallate (E, 282 mg day(-1))+resveratrol (R, 200 mg day(-1)) and E+R+80 mg day(-1) soy isoflavones (S) or placebo capsules (PLA) were supplemented twice daily for a period of 3 days. On day 3, circulating metabolite concentrations, EE and substrate oxidation (using indirect calorimetry) were measured during fasting and postprandial conditions for 6 h (high-fat-mixed meal (2.6 MJ, 61.2 E% fat)). Short-term supplementation of E+R increased resting EE (E+R vs PLA: 5.45±0.24 vs 5.23±0.25 kJ min(-1), P=0.039), whereas both E+R (699±18 kJ 120 min(-1) vs 676±20 kJ 120 min(-1), P=0.028) and E+R+S (704±18 kJ 120 min(-1) vs 676±20 kJ 120 min(-1), P=0.014) increased 2-4 h-postprandial EE compared with PLA. Metabolic flexibility, calculated as the postprandial increase to the highest respiratory quotient achieved, tended to be improved by E+R compared with PLA and E+R+S only in men (E+R vs PLA: 0.11±0.02 vs 0.06±0.02, P=0.059; E+R+S: 0.03±0.02, P=0.009). E+R+S significantly increased fasting plasma free fatty acid (P=0.064) and glycerol (P=0.021) concentrations compared with PLA. We demonstrated for the first time that combined E+R supplementation for 3 days significantly increased fasting and postprandial EE, which was accompanied by improved metabolic flexibility in men but not in women. Addition of soy isoflavones partially reversed these effects possibly due to their higher lipolytic potential. The present findings may imply that long-term supplementation of these dosages of epigallocatechin-gallate combined with resveratrol may improve metabolic health and body weight regulation. Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The present study investigated the effects of short-term supplementation of two combinations of polyphenols on energy expenditure (EE) and substrate metabolism in overweight subjects. Eighteen healthy overweight volunteers (9 women, 9 men; age 35±2.5 years; body mass index 28.9±0.4kgm(-2)) participated in a randomized, double-blind cross-over trial. Combinations of epigallocatechin-gallate (E, 282mgday(-1))+resveratrol (R, 200mgday(-1)) and E+R+80mgday(-1) soy isoflavones (S) or placebo capsules (PLA) were supplemented twice daily for a period of 3 days. On day 3, circulating metabolite concentrations, EE and substrate oxidation (using indirect calorimetry) were measured during fasting and postprandial conditions for 6h (high-fat-mixed meal (2.6MJ, 61.2 E% fat)). Short-term supplementation of E+R increased resting EE (E+R vs PLA: 5.45±0.24 vs 5.23±0.25kJmin(-1), P=0.039), whereas both E+R (699±18kJ120min(-1) vs 676±20kJ120min(-1), P=0.028) and E+R+S (704±18kJ120min(-1) vs 676±20kJ120min(-1), P=0.014) increased 2-4h-postprandial EE compared with PLA. Metabolic flexibility, calculated as the postprandial increase to the highest respiratory quotient achieved, tended to be improved by E+R compared with PLA and E+R+S only in men (E+R vs PLA: 0.11±0.02 vs 0.06±0.02, P=0.059; E+R+S: 0.03±0.02, P=0.009). E+R+S significantly increased fasting plasma free fatty acid (P=0.064) and glycerol (P=0.021) concentrations compared with PLA. We demonstrated for the first time that combined E+R supplementation for 3 days significantly increased fasting and postprandial EE, which was accompanied by improved metabolic flexibility in men but not in women. Addition of soy isoflavones partially reversed these effects possibly due to their higher lipolytic potential. The present findings may imply that long-term supplementation of these dosages of epigallocatechin-gallate combined with resveratrol may improve metabolic health and body weight regulation. International Journal of Obesity (2014) 38, 698-706; doi:10.1038/ijo.2013.231 Background and Objectives:Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The present study investigated the effects of short-term supplementation of two combinations of polyphenols on energy expenditure (EE) and substrate metabolism in overweight subjects.Subjects and Methods:Eighteen healthy overweight volunteers (9 women, 9 men; age 35±2.5 years; body mass index 28.9±0.4 kg m−2) participated in a randomized, double-blind cross-over trial. Combinations of epigallocatechin-gallate (E, 282 mg day−1)+resveratrol (R, 200 mg day−1) and E+R+80 mg day−1 soy isoflavones (S) or placebo capsules (PLA) were supplemented twice daily for a period of 3 days. On day 3, circulating metabolite concentrations, EE and substrate oxidation (using indirect calorimetry) were measured during fasting and postprandial conditions for 6 h (high-fat-mixed meal (2.6 MJ, 61.2 E% fat)).Results:Short-term supplementation of E+R increased resting EE (E+R vs PLA: 5.45±0.24 vs 5.23±0.25 kJ min−1, P=0.039), whereas both E+R (699±18 kJ 120 min−1 vs 676±20 kJ 120 min−1, P=0.028) and E+R+S (704±18 kJ 120 min−1 vs 676±20 kJ 120 min−1, P=0.014) increased 2–4 h-postprandial EE compared with PLA. Metabolic flexibility, calculated as the postprandial increase to the highest respiratory quotient achieved, tended to be improved by E+R compared with PLA and E+R+S only in men (E+R vs PLA: 0.11±0.02 vs 0.06±0.02, P=0.059; E+R+S: 0.03±0.02, P=0.009). E+R+S significantly increased fasting plasma free fatty acid (P=0.064) and glycerol (P=0.021) concentrations compared with PLA.Conclusions:We demonstrated for the first time that combined E+R supplementation for 3 days significantly increased fasting and postprandial EE, which was accompanied by improved metabolic flexibility in men but not in women. Addition of soy isoflavones partially reversed these effects possibly due to their higher lipolytic potential. The present findings may imply that long-term supplementation of these dosages of epigallocatechin-gallate combined with resveratrol may improve metabolic health and body weight regulation. Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The present study investigated the effects of short-term supplementation of two combinations of polyphenols on energy expenditure (EE) and substrate metabolism in overweight subjects.BACKGROUND AND OBJECTIVESImpaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The present study investigated the effects of short-term supplementation of two combinations of polyphenols on energy expenditure (EE) and substrate metabolism in overweight subjects.Eighteen healthy overweight volunteers (9 women, 9 men; age 35±2.5 years; body mass index 28.9±0.4 kg m(-2)) participated in a randomized, double-blind cross-over trial. Combinations of epigallocatechin-gallate (E, 282 mg day(-1))+resveratrol (R, 200 mg day(-1)) and E+R+80 mg day(-1) soy isoflavones (S) or placebo capsules (PLA) were supplemented twice daily for a period of 3 days. On day 3, circulating metabolite concentrations, EE and substrate oxidation (using indirect calorimetry) were measured during fasting and postprandial conditions for 6 h (high-fat-mixed meal (2.6 MJ, 61.2 E% fat)).SUBJECTS AND METHODSEighteen healthy overweight volunteers (9 women, 9 men; age 35±2.5 years; body mass index 28.9±0.4 kg m(-2)) participated in a randomized, double-blind cross-over trial. Combinations of epigallocatechin-gallate (E, 282 mg day(-1))+resveratrol (R, 200 mg day(-1)) and E+R+80 mg day(-1) soy isoflavones (S) or placebo capsules (PLA) were supplemented twice daily for a period of 3 days. On day 3, circulating metabolite concentrations, EE and substrate oxidation (using indirect calorimetry) were measured during fasting and postprandial conditions for 6 h (high-fat-mixed meal (2.6 MJ, 61.2 E% fat)).Short-term supplementation of E+R increased resting EE (E+R vs PLA: 5.45±0.24 vs 5.23±0.25 kJ min(-1), P=0.039), whereas both E+R (699±18 kJ 120 min(-1) vs 676±20 kJ 120 min(-1), P=0.028) and E+R+S (704±18 kJ 120 min(-1) vs 676±20 kJ 120 min(-1), P=0.014) increased 2-4 h-postprandial EE compared with PLA. Metabolic flexibility, calculated as the postprandial increase to the highest respiratory quotient achieved, tended to be improved by E+R compared with PLA and E+R+S only in men (E+R vs PLA: 0.11±0.02 vs 0.06±0.02, P=0.059; E+R+S: 0.03±0.02, P=0.009). E+R+S significantly increased fasting plasma free fatty acid (P=0.064) and glycerol (P=0.021) concentrations compared with PLA.RESULTSShort-term supplementation of E+R increased resting EE (E+R vs PLA: 5.45±0.24 vs 5.23±0.25 kJ min(-1), P=0.039), whereas both E+R (699±18 kJ 120 min(-1) vs 676±20 kJ 120 min(-1), P=0.028) and E+R+S (704±18 kJ 120 min(-1) vs 676±20 kJ 120 min(-1), P=0.014) increased 2-4 h-postprandial EE compared with PLA. Metabolic flexibility, calculated as the postprandial increase to the highest respiratory quotient achieved, tended to be improved by E+R compared with PLA and E+R+S only in men (E+R vs PLA: 0.11±0.02 vs 0.06±0.02, P=0.059; E+R+S: 0.03±0.02, P=0.009). E+R+S significantly increased fasting plasma free fatty acid (P=0.064) and glycerol (P=0.021) concentrations compared with PLA.We demonstrated for the first time that combined E+R supplementation for 3 days significantly increased fasting and postprandial EE, which was accompanied by improved metabolic flexibility in men but not in women. Addition of soy isoflavones partially reversed these effects possibly due to their higher lipolytic potential. The present findings may imply that long-term supplementation of these dosages of epigallocatechin-gallate combined with resveratrol may improve metabolic health and body weight regulation.CONCLUSIONSWe demonstrated for the first time that combined E+R supplementation for 3 days significantly increased fasting and postprandial EE, which was accompanied by improved metabolic flexibility in men but not in women. Addition of soy isoflavones partially reversed these effects possibly due to their higher lipolytic potential. The present findings may imply that long-term supplementation of these dosages of epigallocatechin-gallate combined with resveratrol may improve metabolic health and body weight regulation. |
Audience | Academic |
Author | Most, J Blaak, E E Jocken, J W E Goossens, G H |
Author_xml | – sequence: 1 givenname: J surname: Most fullname: Most, J email: jasper.most@maastrichtuniversity.nl organization: Department of Human Biology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center+ – sequence: 2 givenname: G H surname: Goossens fullname: Goossens, G H organization: Department of Human Biology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center+ – sequence: 3 givenname: J W E surname: Jocken fullname: Jocken, J W E organization: Department of Human Biology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center+ – sequence: 4 givenname: E E surname: Blaak fullname: Blaak, E E organization: Department of Human Biology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center+ |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28416332$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/24317366$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkstu1DAUhiNURKeFHWtkCYFYkMGXOJdlVXGTKrEA1pbjnEw8cuxgOy3zOLwpjmYqplUBeWHJ_v5z_c-yE-ssZNlzgtcEs_qd3ro1xYStKSOPshUpqjLnRVOdZCvMcJVjXvLT7CyELcaYc0yfZKe0YKRiZbnKfn0dnI95BD-iME-TgRFslFE7i250HJBEYQKle62QcmOr7f7P9ajTEKXfocmZ3TSAdSYgbZUHGSAgsOA3OwQ_J7CdjrMHJG2HpEmpQkrVhuhlBDSmIK0zOoxJjNw1-BvQmyEuyBZUDE-zx700AZ4d7vPs-4f33y4_5VdfPn6-vLjKFS_KmDNVA-lJI0nBe4wJNLLFhEvCOigxKNpyJhlQytNAsJRFT2mvWEEJUU3btOw8e7OPO3n3Y4YQxaiDAmOkBTcHQWpWMcpqXP8f5ZQ0hBFcJfTlPXTrZm9TI4KWrCGUM07_RaVYuCkrjI-ojTQgtO1dGqFaUosLVtZ1UfOmSNT6ASqdDkatknd6nd7vCF4fCQZIKxqCM_Oy53AXfHGocm5H6MTk9ZgMIG7dlIBXB0AGJU3vpVU6_OHqgpSMLY3QPae8C8FDL5Teey6Vqo0gWCzWFsnaYrG2SNZOorf3RLdx_4LnezwkzG7AH430If43brIIvA |
CODEN | IJOBDP |
CitedBy_id | crossref_primary_10_1080_10408398_2018_1536646 crossref_primary_10_1021_acs_jafc_8b04198 crossref_primary_10_3945_ajcn_115_122937 crossref_primary_10_1111_1541_4337_12359 crossref_primary_10_2337_db15_1661 crossref_primary_10_1080_10408398_2014_980499 crossref_primary_10_1016_j_aquaculture_2024_740967 crossref_primary_10_1080_07357907_2022_2115057 crossref_primary_10_3390_molecules23071814 crossref_primary_10_3390_nu9050452 crossref_primary_10_1038_srep17896 crossref_primary_10_1111_obr_12298 crossref_primary_10_1080_10408398_2022_2104805 crossref_primary_10_3945_jn_114_207829 crossref_primary_10_1016_j_clnu_2016_11_002 crossref_primary_10_1007_s00204_022_03391_2 crossref_primary_10_1016_j_biopha_2017_08_070 crossref_primary_10_1080_10408398_2021_1965536 crossref_primary_10_1021_acs_jafc_3c08492 crossref_primary_10_1080_09637486_2018_1452900 crossref_primary_10_1111_jhn_13350 crossref_primary_10_3390_molecules22081329 crossref_primary_10_1007_s00394_019_01946_1 crossref_primary_10_1038_ejcn_2017_89 crossref_primary_10_3390_molecules24091655 crossref_primary_10_1038_nrendo_2016_142 crossref_primary_10_1016_j_arr_2015_01_002 crossref_primary_10_1039_C7FO01236E crossref_primary_10_1016_j_clnu_2024_09_027 crossref_primary_10_1007_s11010_021_04106_4 crossref_primary_10_1371_journal_pone_0137809 crossref_primary_10_1007_s00394_016_1209_x crossref_primary_10_1371_journal_pone_0153134 crossref_primary_10_1080_15592294_2016_1278097 crossref_primary_10_2174_1871530323666221107092553 crossref_primary_10_3109_09637486_2015_1035231 crossref_primary_10_1002_oby_23689 crossref_primary_10_1016_j_nut_2020_111045 crossref_primary_10_1021_acs_jafc_7b04647 crossref_primary_10_1155_2018_7406946 crossref_primary_10_1186_s12986_016_0143_5 crossref_primary_10_1002_ptr_6547 crossref_primary_10_15384_kjhp_2014_14_2_59 crossref_primary_10_1113_JP278920 crossref_primary_10_1210_jendso_bvad095 crossref_primary_10_1080_10408398_2014_989958 crossref_primary_10_1080_10408398_2022_2159921 crossref_primary_10_1111_jfbc_12954 crossref_primary_10_3390_nu11040776 crossref_primary_10_1111_obr_12409 crossref_primary_10_2174_0929866528666210127152359 crossref_primary_10_1016_j_jare_2025_01_014 crossref_primary_10_1080_21623945_2018_1469942 crossref_primary_10_1155_2021_6331630 crossref_primary_10_1016_j_cofs_2014_11_008 crossref_primary_10_1186_s12906_024_04487_1 crossref_primary_10_1016_j_foodres_2018_02_027 crossref_primary_10_1096_fj_15_271833 |
Cites_doi | 10.1016/j.nutres.2012.06.002 10.1016/j.metabol.2011.08.003 10.1210/jc.2005-1598 10.3109/13697137.2011.631062 10.1089/jmf.2012.0062 10.1016/j.cmet.2012.09.015 10.1079/BJN20051502 10.1111/nyas.12141 10.1093/jn/137.12.2668 10.1016/S0960-0760(00)00172-2 10.4196/kjpp.2008.12.4.155 10.1152/jappl.1983.55.2.628 10.18632/aging.100445 10.1093/ajcn/87.3.778 10.1210/jc.2010-0822 10.1016/j.bcp.2011.03.012 10.1007/s12263-011-0260-8 10.1371/journal.pone.0051648 10.1016/j.cell.2006.11.013 10.1111/j.1753-0407.2009.00045.x 10.1080/07315724.2007.10719627 10.1017/S0007114509371779 10.1016/j.cmet.2011.10.002 10.1038/sj.ijo.0802926 10.1016/j.phymed.2004.07.001 10.1007/s13105-011-0086-2 10.1111/j.1467-789X.2008.00544.x 10.1038/oby.2010.181 10.1289/ehp.10413 10.1210/jc.2010-0702 10.1111/nyas.12185 10.1016/j.ecl.2008.09.002 10.1093/ajcn/70.6.1040 10.1152/jappl.1997.83.6.2064 10.1038/ajh.2009.228 10.1159/000084175 10.2337/dc06-0560 10.1038/ejcn.2010.47 10.1079/BJN20051580 10.1016/j.physbeh.2007.10.010 10.2337/diabetes.50.11.2548 10.1016/j.diabres.2012.02.029 10.2337/db10-0519 10.1113/jphysiol.1949.sp004363 10.1152/ajpregu.00693.2004 10.1210/jcem.87.5.8628 10.1038/nature05354 10.1111/j.1464-5491.2008.02417.x 10.1016/j.jsbmb.2005.04.033 10.2337/db12-0975 10.1271/bbb.80563 10.1056/NEJM200105033441801 |
ContentType | Journal Article |
Copyright | Macmillan Publishers Limited 2014 2015 INIST-CNRS COPYRIGHT 2014 Nature Publishing Group Copyright Nature Publishing Group May 2014 Macmillan Publishers Limited 2014. |
Copyright_xml | – notice: Macmillan Publishers Limited 2014 – notice: 2015 INIST-CNRS – notice: COPYRIGHT 2014 Nature Publishing Group – notice: Copyright Nature Publishing Group May 2014 – notice: Macmillan Publishers Limited 2014. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7T2 7TK 7TS 7X2 7X7 7XB 88E 88G 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ATCPS AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0K M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 |
DOI | 10.1038/ijo.2013.231 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health and Safety Science Abstracts (Full archive) Neurosciences Abstracts Physical Education Index Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Agriculture Science Database ProQuest Health & Medical Collection Medical Database Psychology Database Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China Physical Education Index Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection Biological Science Collection Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Physical Education Index MEDLINE Agricultural Science Database Agricultural Science Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health Diet & Clinical Nutrition Recreation & Sports |
EISSN | 1476-5497 |
EndPage | 706 |
ExternalDocumentID | 3294506381 A368848594 24317366 28416332 10_1038_ijo_2013_231 |
Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Netherlands |
GeographicLocations_xml | – name: Netherlands |
GroupedDBID | .55 .GJ 29J 36B 39C 5RE 7X2 7X7 8R4 8R5 A8Z ABDBF ABOCM ABUWG ACUHS ADBBV AFFNX AI. ALMA_UNASSIGNED_HOLDINGS ATCPS AZQEC B0M BAWUL BENPR BHPHI BPHCQ DIK DWQXO EAD EAP EBC EBD EBS EMB EMK EMOBN EPL ESX F5P FYUFA GNUQQ HCIFZ IAO IHR ITC J5H M0K M1P M2M MVM NAO OK1 Q2X RNT RNTTT SV3 TUS VH1 WH7 X7M ZGI ZXP ~8M AAYXX CITATION IQODW --- -Q- ..I .L3 .XZ 0R~ 1CY 2FS 2WC 4.4 406 53G 5GY 70F 88E 8AO 8C1 8FE 8FH 8FI 8FJ AACDK AAHBH AANZL AASML AATNV AAWTL AAYZH ABAKF ABAWZ ABCQX ABDBE ABIVO ABJNI ABLJU ABZZP ACAOD ACGFS ACKTT ACPRK ACRQY ACZOJ ADHUB AEFQL AEJRE AEMSY AENEX AEUYN AEVLU AEXYK AFBBN AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALIPV AMYLF APEBS AXYYD AYFIA BBNVY BKKNO BVXVI CCPQU CGR CS3 CUY CVF DNIVK DPUIP DU5 E3Z EBLON ECM EE. EIF EIOEI EJD FDQFY FERAY FIGPU FIZPM FSGXE HMCUK HZ~ IHW INH INR IPY IWAJR JSO JZLTJ KQ8 L7B M7P NPM NQJWS O9- OVD P2P P6G PHGZT PQQKQ PROAC PSQYO PSYQQ RNS ROL SNX SNYQT SOHCF SOJ SRMVM SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG UKHRP YCJ ~KM 3V. 7T2 7TK 7TS 7XB 8FK C1K K9. LK8 PHGZM PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 ABBRH ABFSG ABRTQ ACSTC AEZWR AFDZB AFHIU AHWEU AIXLP ATHPR |
ID | FETCH-LOGICAL-c546t-3c8e1f19a145f001e9ab015a13de60ec2b53a3e2250560aa4f22fc34211c9b9b3 |
IEDL.DBID | 7X7 |
ISSN | 0307-0565 1476-5497 |
IngestDate | Fri Jul 11 09:38:55 EDT 2025 Mon Jul 21 10:31:24 EDT 2025 Thu Jul 17 01:56:40 EDT 2025 Thu Jul 17 02:00:24 EDT 2025 Tue Jun 17 21:15:17 EDT 2025 Tue Jun 10 20:45:46 EDT 2025 Thu May 22 21:20:27 EDT 2025 Thu Apr 03 07:02:07 EDT 2025 Wed Apr 02 07:17:44 EDT 2025 Thu Apr 24 22:53:55 EDT 2025 Tue Jul 01 03:01:52 EDT 2025 Fri Feb 21 02:39:37 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | epigallocatechin-gallate polyphenols human substrate metabolism resveratrol Short term Energy metabolism Body weight Overweight Polyphenol Energetic cost Resveratrol Supplementation Nutritional status Food Human Obesity Nutrition Nutrition disorder Metabolic diseases Corporal biometry Increase Antioxidant Stilbene derivatives Feeding Substrate Diet Phenols |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c546t-3c8e1f19a145f001e9ab015a13de60ec2b53a3e2250560aa4f22fc34211c9b9b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
PMID | 24317366 |
PQID | 1520967002 |
PQPubID | 38864 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1837323808 proquest_miscellaneous_1521913107 proquest_journals_2639125352 proquest_journals_1520967002 gale_infotracmisc_A368848594 gale_infotracacademiconefile_A368848594 gale_healthsolutions_A368848594 pubmed_primary_24317366 pascalfrancis_primary_28416332 crossref_citationtrail_10_1038_ijo_2013_231 crossref_primary_10_1038_ijo_2013_231 springer_journals_10_1038_ijo_2013_231 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-05-01 |
PublicationDateYYYYMMDD | 2014-05-01 |
PublicationDate_xml | – month: 05 year: 2014 text: 2014-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: Basingstoke – name: England |
PublicationTitle | International Journal of Obesity |
PublicationTitleAbbrev | Int J Obes |
PublicationTitleAlternate | Int J Obes (Lond) |
PublicationYear | 2014 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Lonac, Richards, Schweder, Johnson, Bell (CR18) 2010; 19 Hamman, Wing, Edelstein, Lachin, Bray, Delahanty (CR53) 2006; 29 Murase, Haramizu, Shimotoyodome, Nagasawa, Tokimitsu (CR38) 2005; 288 Thielecke, Rahn, Bohnke, Adams, Birkenfeld, Jordan (CR15) 2010; 64 Ullmann, Haller, Bakker, Brink, Weber (CR29) 2005; 12 Lara-Castro, Garvey (CR3) 2008; 37 Rayalam, Della-Fera, Yang, Park, Ambati, Baile (CR26) 2007; 137 Tuomilehto, Lindstrom, Eriksson, Valle, Hamalainen, Ilanne-Parikka (CR8) 2001; 344 Mohamed Salih, Nallasamy, Muniyandi, Periyasami, Carani Venkatraman (CR21) 2009; 1 Diepvens, Kovacs, Nijs, Vogels, Westerterp-Plantenga (CR33) 2005; 94 Goossens (CR2) 2008; 94 Thandapilly, Wojciechowski, Behbahani, Louis, Yu, Juric (CR39) 2011; 23 Lee, Kim (CR44) 2009; 73 Zhang, Chen, Zheng, Zeng, Li, Xiao (CR48) 2012; 97 Poulsen, Vestergaard, Clasen, Radko, Christensen, Stodkilde-Jorgensen (CR25) 2012; 62 Timmers, Hesselink, Schrauwen (CR51) 2013; 1290 Yeung, Zhang, Mumford, Ye, Trevisan, Chen (CR46) 2010; 95 Venables, Hulston, Cox, Jeukendrup (CR19) 2008; 87 Hoeks, van Herpen, Mensink, Moonen-Kornips, van Beurden, Hesselink (CR50) 2010; 59 Arunkumar, Anuradha (CR24) 2012; 32 Rosenbaum, Murphy, Heymsfield, Matthews, Leibel (CR41) 2002; 87 Timmers, Konings, Bilet, Houtkooper, van de Weijer, Goossens (CR12) 2011; 14 Cederroth, Vinciguerra, Kuhne, Madani, Doerge, Visser (CR22) 2007; 115 Mensink, Blaak, van Baak, Wagenmakers, Saris (CR4) 2001; 50 Lagouge, Argmann, Gerhart-Hines, Meziane, Lerin, Daussin (CR11) 2006; 127 Poulsen, Jorgensen, Jessen, Richelsen, Pedersen (CR52) 2013; 1290 Llaneza, Gonzalez, Fernandez-Inarrea, Alonso, Diaz, Perez-Lopez (CR23) 2012; 15 Yoshino, Conte, Fontana, Mittendorfer, Imai, Schechtman (CR34) 2012; 16 Chomentowski, Coen, Radikova, Goodpaster, Toledo (CR6) 2011; 96 Frayn (CR31) 1983; 55 Arias, Macarulla, Aguirre, Martinez-Castano, Gomez-Zorita, Miranda (CR35) 2012; 67 Klaus, Pultz, Thone-Reineke, Wolfram (CR37) 2005; 29 Klaus, Keipert, Rossmeisl, Kopecky (CR43) 2012; 7 Szkudelska, Nogowski, Szkudelski (CR49) 2000; 75 Cardoso, Salgado, Cesar Mde, Donado-Pestana (CR32) 2012; 16 Szkudelski, Nogowski, Pruszynska-Oszmalek, Kaczmarek, Szkudelska (CR42) 2005; 96 Blaak, Hul, Verdich, Stich, Martinez, Petersen (CR5) 2006; 91 Baur, Pearson, Price, Jamieson, Lerin, Kalra (CR10) 2006; 444 Timmers, Auwerx, Schrauwen (CR45) 2012; 4 Corpeleijn, Saris, Blaak (CR1) 2009; 10 Roumen, Corpeleijn, Feskens, Mensink, Saris, Blaak (CR9) 2008; 25 Kim, Jin, Choi, Park (CR36) 2011; 81 Berube-Parent, Pelletier, Dore, Tremblay (CR16) 2005; 94 Kang, Hong, Guan, Kim, Yang, Koh (CR47) 2011; 61 Chen, Bakhiet, Hart, Holtzman (CR28) 2005; 49 Gregersen, Bitz, Krog-Mikkelsen, Hels, Kovacs, Rycroft (CR17) 2009; 102 Schoffelen, Westerterp, Saris, Ten Hoor (CR27) 1997; 83 Van Can, Van Dijk, Goossens, Jocken, Hospers, Blaak (CR20) 2010; 11 Boschmann, Thielecke (CR13) 2007; 26 Weir (CR30) 1949; 109 Woo, Na, Lim (CR40) 2008; 12 van de Weijer, Sparks, Phielix, Meex, van Herpen, Hesselink (CR7) 2013; 8 Dulloo, Duret, Rohrer, Girardier, Mensi, Fathi (CR14) 1999; 70 K Szkudelska (BFijo2013231_CR49) 2000; 75 EE Blaak (BFijo2013231_CR5) 2006; 91 S Timmers (BFijo2013231_CR12) 2011; 14 S Mohamed Salih (BFijo2013231_CR21) 2009; 1 S Timmers (BFijo2013231_CR51) 2013; 1290 CR Cederroth (BFijo2013231_CR22) 2007; 115 N Arias (BFijo2013231_CR35) 2012; 67 S Rayalam (BFijo2013231_CR26) 2007; 137 C Lara-Castro (BFijo2013231_CR3) 2008; 37 AG Dulloo (BFijo2013231_CR14) 1999; 70 SC Woo (BFijo2013231_CR40) 2008; 12 RF Hamman (BFijo2013231_CR53) 2006; 29 MM Poulsen (BFijo2013231_CR52) 2013; 1290 E Corpeleijn (BFijo2013231_CR1) 2009; 10 M Lagouge (BFijo2013231_CR11) 2006; 127 J Van Can (BFijo2013231_CR20) 2010; 11 JB Weir (BFijo2013231_CR30) 1949; 109 E Arunkumar (BFijo2013231_CR24) 2012; 32 W Kang (BFijo2013231_CR47) 2011; 61 J Tuomilehto (BFijo2013231_CR8) 2001; 344 J Yoshino (BFijo2013231_CR34) 2012; 16 S Klaus (BFijo2013231_CR43) 2012; 7 MS Lee (BFijo2013231_CR44) 2009; 73 M Rosenbaum (BFijo2013231_CR41) 2002; 87 S Kim (BFijo2013231_CR36) 2011; 81 CY Chen (BFijo2013231_CR28) 2005; 49 J Zhang (BFijo2013231_CR48) 2012; 97 MM Poulsen (BFijo2013231_CR25) 2012; 62 S Timmers (BFijo2013231_CR45) 2012; 4 GH Goossens (BFijo2013231_CR2) 2008; 94 T Murase (BFijo2013231_CR38) 2005; 288 MC Venables (BFijo2013231_CR19) 2008; 87 JA Baur (BFijo2013231_CR10) 2006; 444 GA Cardoso (BFijo2013231_CR32) 2012; 16 K Diepvens (BFijo2013231_CR33) 2005; 94 T van de Weijer (BFijo2013231_CR7) 2013; 8 P Chomentowski (BFijo2013231_CR6) 2011; 96 PF Schoffelen (BFijo2013231_CR27) 1997; 83 J Hoeks (BFijo2013231_CR50) 2010; 59 P Llaneza (BFijo2013231_CR23) 2012; 15 U Ullmann (BFijo2013231_CR29) 2005; 12 M Mensink (BFijo2013231_CR4) 2001; 50 KN Frayn (BFijo2013231_CR31) 1983; 55 SJ Thandapilly (BFijo2013231_CR39) 2011; 23 MC Lonac (BFijo2013231_CR18) 2010; 19 F Thielecke (BFijo2013231_CR15) 2010; 64 S Berube-Parent (BFijo2013231_CR16) 2005; 94 M Boschmann (BFijo2013231_CR13) 2007; 26 S Klaus (BFijo2013231_CR37) 2005; 29 T Szkudelski (BFijo2013231_CR42) 2005; 96 NT Gregersen (BFijo2013231_CR17) 2009; 102 EH Yeung (BFijo2013231_CR46) 2010; 95 C Roumen (BFijo2013231_CR9) 2008; 25 21455758 - J Physiol Biochem. 2011 Sep;67(3):471-7 22497970 - Diabetes Res Clin Pract. 2012 Sep;97(3):474-82 11679433 - Diabetes. 2001 Nov;50(11):2548-54 21106709 - J Clin Endocrinol Metab. 2011 Feb;96(2):494-503 22139637 - Genes Nutr. 2012 Jul;7(3):369-86 18029481 - J Nutr. 2007 Dec;137(12):2668-73 23418416 - PLoS One. 2013;8(2):e51648 Int J Obes (Lond). 2014 May;38(5):752 19026935 - Endocrinol Metab Clin North Am. 2008 Dec;37(4):841-56 23855469 - Ann N Y Acad Sci. 2013 Jul;1290:83-9 9390982 - J Appl Physiol (1985). 1997 Dec;83(6):2064-72 16936160 - Diabetes Care. 2006 Sep;29(9):2102-7 17112576 - Cell. 2006 Dec 15;127(6):1109-22 19445822 - Br J Nutr. 2009 Oct;102(8):1187-94 16008116 - Phytomedicine. 2005 Jun;12(6-7):410-5 22055504 - Cell Metab. 2011 Nov 2;14 (5):612-22 15738931 - Int J Obes (Lond). 2005 Jun;29(6):615-23 20843950 - J Clin Endocrinol Metab. 2010 Dec;95(12):5435-42 20372175 - Eur J Clin Nutr. 2010 Jul;64(7):704-13 18445174 - Diabet Med. 2008 May;25(5):597-605 11333990 - N Engl J Med. 2001 May 3;344(18):1343-50 6618956 - J Appl Physiol Respir Environ Exerc Physiol. 1983 Aug;55(2):628-34 18326618 - Am J Clin Nutr. 2008 Mar;87(3):778-84 15394301 - J Physiol. 1949 Aug;109(1-2):1-9 20725062 - Obesity (Silver Spring). 2011 Feb;19(2):298-304 20923528 - J Diabetes. 2009 Dec;1(4):278-87 22436213 - Aging (Albany NY). 2012 Mar;4(3):146-58 10584049 - Am J Clin Nutr. 1999 Dec;70(6):1040-5 23140132 - J Med Food. 2013 Feb;16(2):120-7 16351782 - Br J Nutr. 2005 Dec;94(6):1026-34 11994393 - J Clin Endocrinol Metab. 2002 May;87(5):2391-4 19967050 - Korean J Physiol Pharmacol. 2008 Aug;12(4):155-64 21439945 - Biochem Pharmacol. 2011 Jun 1;81(11):1343-51 18037457 - Physiol Behav. 2008 May 23;94(2):206-18 20573749 - Diabetes. 2010 Sep;59(9):2117-25 11282281 - J Steroid Biochem Mol Biol. 2000 Dec 31;75(4-5):265-71 17906192 - J Am Coll Nutr. 2007 Aug;26(4):389S-395S 15970440 - J Steroid Biochem Mol Biol. 2005 Aug;96(3-4):301-7 19202275 - Biosci Biotechnol Biochem. 2009 Feb;73(2):434-6 15735366 - Ann Nutr Metab. 2005 Jan-Feb;49(1):33-41 22191384 - Climacteric. 2012 Dec;15(6):611-20 15563575 - Am J Physiol Regul Integr Comp Physiol. 2005 Mar;288(3):R708-15 17938737 - Environ Health Perspect. 2007 Oct;115(10):1467-73 23102619 - Cell Metab. 2012 Nov 7;16(5):658-64 16176615 - Br J Nutr. 2005 Sep;94(3):432-6 21945106 - Metabolism. 2012 Mar;61(3):424-33 23193181 - Diabetes. 2013 Apr;62(4):1186-95 19207879 - Obes Rev. 2009 Mar;10(2):178-93 19942861 - Am J Hypertens. 2010 Feb;23 (2):192-6 23855468 - Ann N Y Acad Sci. 2013 Jul;1290:74-82 17086191 - Nature. 2006 Nov 16;444(7117):337-42 22935345 - Nutr Res. 2012 Aug;32(8):617-25 16449343 - J Clin Endocrinol Metab. 2006 Apr;91(4):1462-9 |
References_xml | – volume: 32 start-page: 617 year: 2012 end-page: 625 ident: CR24 article-title: Genistein promotes insulin action through adenosine monophosphate-activated protein kinase activation and p70 ribosomal protein S6 kinase 1 inhibition in the skeletal muscle of mice fed a high energy diet publication-title: Nutr Res doi: 10.1016/j.nutres.2012.06.002 – volume: 61 start-page: 424 year: 2011 end-page: 433 ident: CR47 article-title: Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: and experiments in rodents publication-title: Metabolism doi: 10.1016/j.metabol.2011.08.003 – volume: 91 start-page: 1462 year: 2006 end-page: 1469 ident: CR5 article-title: Fat oxidation before and after a high fat load in the obese insulin-resistant state publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-1598 – volume: 15 start-page: 611 year: 2012 end-page: 620 ident: CR23 article-title: Soy isoflavones improve insulin sensitivity without changing serum leptin among postmenopausal women publication-title: Climacteric doi: 10.3109/13697137.2011.631062 – volume: 16 start-page: 120 year: 2012 end-page: 127 ident: CR32 article-title: The effects of green tea consumption and resistance training on body composition and resting metabolic rate in overweight or obese women publication-title: J Med Food doi: 10.1089/jmf.2012.0062 – volume: 16 start-page: 658 year: 2012 end-page: 664 ident: CR34 article-title: Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance publication-title: Cell Metab doi: 10.1016/j.cmet.2012.09.015 – volume: 94 start-page: 432 year: 2005 end-page: 436 ident: CR16 article-title: Effects of encapsulated green tea and Guarana extracts containing a mixture of epigallocatechin-3-gallate and caffeine on 24 h energy expenditure and fat oxidation in men publication-title: Br J Nutr doi: 10.1079/BJN20051502 – volume: 1290 start-page: 74 year: 2013 end-page: 82 ident: CR52 article-title: Resveratrol in metabolic health: an overview of the current evidence and perspectives publication-title: Ann NY Acad Sci doi: 10.1111/nyas.12141 – volume: 137 start-page: 2668 year: 2007 end-page: 2673 ident: CR26 article-title: Resveratrol potentiates genistein's antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes publication-title: J Nutr doi: 10.1093/jn/137.12.2668 – volume: 75 start-page: 265 year: 2000 end-page: 271 ident: CR49 article-title: Genistein affects lipogenesis and lipolysis in isolated rat adipocytes publication-title: J Steroid Biochem Mol Biol doi: 10.1016/S0960-0760(00)00172-2 – volume: 12 start-page: 155 year: 2008 end-page: 164 ident: CR40 article-title: Resveratrol inhibits nicotinic stimulation-evoked catecholamine release from the adrenal medulla publication-title: Korean J Physiol Pharmacol doi: 10.4196/kjpp.2008.12.4.155 – volume: 55 start-page: 628 year: 1983 end-page: 634 ident: CR31 article-title: Calculation of substrate oxidation rates from gaseous exchange publication-title: J Appl Physiol doi: 10.1152/jappl.1983.55.2.628 – volume: 4 start-page: 146 year: 2012 end-page: 158 ident: CR45 article-title: The journey of resveratrol from yeast to human publication-title: Aging (Albany NY) doi: 10.18632/aging.100445 – volume: 87 start-page: 778 year: 2008 end-page: 784 ident: CR19 article-title: Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans publication-title: Am J Clin Nutr doi: 10.1093/ajcn/87.3.778 – volume: 344 start-page: 1343 year: 2001 end-page: 1350 ident: CR8 article-title: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance publication-title: N Engl J Med – volume: 96 start-page: 494 year: 2011 end-page: 503 ident: CR6 article-title: Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2010-0822 – volume: 81 start-page: 1343 year: 2011 end-page: 1351 ident: CR36 article-title: Resveratrol exerts anti-obesity effects mechanisms involving down-regulation of adipogenic and inflammatory processes in mice publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2011.03.012 – volume: 7 start-page: 369 year: 2012 end-page: 386 ident: CR43 article-title: Augmenting energy expenditure by mitochondrial uncoupling: a role of AMP-activated protein kinase publication-title: Genes Nutr doi: 10.1007/s12263-011-0260-8 – volume: 8 start-page: e51648 year: 2013 ident: CR7 article-title: Relationships between mitochondrial function and metabolic flexibility in type 2 diabetes mellitus publication-title: PLoS One doi: 10.1371/journal.pone.0051648 – volume: 127 start-page: 1109 year: 2006 end-page: 1122 ident: CR11 article-title: Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha publication-title: Cell doi: 10.1016/j.cell.2006.11.013 – volume: 1 start-page: 278 year: 2009 end-page: 287 ident: CR21 article-title: Genistein improves liver function and attenuates non-alcoholic fatty liver disease in a rat model of insulin resistance publication-title: J Diabetes doi: 10.1111/j.1753-0407.2009.00045.x – volume: 26 start-page: 389S year: 2007 end-page: 395SS ident: CR13 article-title: The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study publication-title: J Am Coll Nutr doi: 10.1080/07315724.2007.10719627 – volume: 102 start-page: 1187 year: 2009 end-page: 1194 ident: CR17 article-title: Effect of moderate intakes of different tea catechins and caffeine on acute measures of energy metabolism under sedentary conditions publication-title: Br J Nutr doi: 10.1017/S0007114509371779 – volume: 14 start-page: 612 year: 2011 end-page: 622 ident: CR12 article-title: Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans publication-title: Cell Metab doi: 10.1016/j.cmet.2011.10.002 – volume: 29 start-page: 615 year: 2005 end-page: 623 ident: CR37 article-title: Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation publication-title: Int J Obes (Lond) doi: 10.1038/sj.ijo.0802926 – volume: 12 start-page: 410 year: 2005 end-page: 415 ident: CR29 article-title: Epigallocatechin gallate (EGCG) (TEAVIGO) does not impair nonhaem-iron absorption in man publication-title: Phytomedicine doi: 10.1016/j.phymed.2004.07.001 – volume: 67 start-page: 471 year: 2012 end-page: 477 ident: CR35 article-title: The combination of resveratrol and conjugated linoleic acid is not useful in preventing obesity publication-title: J Physiol Biochem doi: 10.1007/s13105-011-0086-2 – volume: 10 start-page: 178 year: 2009 end-page: 193 ident: CR1 article-title: Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle publication-title: Obes Rev doi: 10.1111/j.1467-789X.2008.00544.x – volume: 19 start-page: 298 year: 2010 end-page: 304 ident: CR18 article-title: Influence of short-term consumption of the caffeine-free, epigallocatechin-3-gallate supplement, Teavigo, on resting metabolism and the thermic effect of feeding publication-title: Obesity (Silver Spring) doi: 10.1038/oby.2010.181 – volume: 115 start-page: 1467 year: 2007 end-page: 1473 ident: CR22 article-title: A phytoestrogen-rich diet increases energy expenditure and decreases adiposity in mice publication-title: Environ Health Perspect doi: 10.1289/ehp.10413 – volume: 95 start-page: 5435 year: 2010 end-page: 5442 ident: CR46 article-title: Longitudinal study of insulin resistance and sex hormones over the menstrual cycle: the BioCycle Study publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2010-0702 – volume: 1290 start-page: 83 year: 2013 end-page: 89 ident: CR51 article-title: Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits? publication-title: Ann NY Acad Sci doi: 10.1111/nyas.12185 – volume: 37 start-page: 841 year: 2008 end-page: 856 ident: CR3 article-title: Intracellular lipid accumulation in liver and muscle and the insulin resistance syndrome publication-title: Endocrinol Metab Clin North Am doi: 10.1016/j.ecl.2008.09.002 – volume: 70 start-page: 1040 year: 1999 end-page: 1045 ident: CR14 article-title: Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans publication-title: Am J Clin Nutr doi: 10.1093/ajcn/70.6.1040 – volume: 83 start-page: 2064 year: 1997 end-page: 2072 ident: CR27 article-title: A dual-respiration chamber system with automated calibration publication-title: J Appl Physiol doi: 10.1152/jappl.1997.83.6.2064 – volume: 23 start-page: 192 year: 2011 end-page: 196 ident: CR39 article-title: Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure publication-title: Am J Hypertens doi: 10.1038/ajh.2009.228 – volume: 49 start-page: 33 year: 2005 end-page: 41 ident: CR28 article-title: Isoflavones improve plasma homocysteine status and antioxidant defense system in healthy young men at rest but do not ameliorate oxidative stress induced by 80% VO2pk exercise publication-title: Ann Nutr Metab doi: 10.1159/000084175 – volume: 29 start-page: 2102 year: 2006 end-page: 2107 ident: CR53 article-title: Effect of weight loss with lifestyle intervention on risk of diabetes publication-title: Diabetes Care doi: 10.2337/dc06-0560 – volume: 64 start-page: 704 year: 2010 end-page: 713 ident: CR15 article-title: Epigallocatechin-3-gallate and postprandial fat oxidation in overweight/obese male volunteers: a pilot study publication-title: Eur J Clin Nutr doi: 10.1038/ejcn.2010.47 – volume: 94 start-page: 1026 year: 2005 end-page: 1034 ident: CR33 article-title: Effect of green tea on resting energy expenditure and substrate oxidation during weight loss in overweight females publication-title: Br J Nutr doi: 10.1079/BJN20051580 – volume: 94 start-page: 206 year: 2008 end-page: 218 ident: CR2 article-title: The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance publication-title: Physiol Behav doi: 10.1016/j.physbeh.2007.10.010 – volume: 50 start-page: 2548 year: 2001 end-page: 2554 ident: CR4 article-title: Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes publication-title: Diabetes doi: 10.2337/diabetes.50.11.2548 – volume: 97 start-page: 474 year: 2012 end-page: 482 ident: CR48 article-title: The protective effect of resveratrol on islet insulin secretion and morphology in mice on a high-fat diet publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2012.02.029 – volume: 59 start-page: 2117 year: 2010 end-page: 2125 ident: CR50 article-title: Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance publication-title: Diabetes doi: 10.2337/db10-0519 – volume: 109 start-page: 1 year: 1949 end-page: 9 ident: CR30 article-title: New methods for calculating metabolic rate with special reference to protein metabolism publication-title: J Physiol doi: 10.1113/jphysiol.1949.sp004363 – volume: 288 start-page: R708 year: 2005 end-page: R715 ident: CR38 article-title: Green tea extract improves endurance capacity and increases muscle lipid oxidation in mice publication-title: Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.00693.2004 – volume: 87 start-page: 2391 year: 2002 end-page: 2394 ident: CR41 article-title: Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem.87.5.8628 – volume: 444 start-page: 337 year: 2006 end-page: 342 ident: CR10 article-title: Resveratrol improves health and survival of mice on a high-calorie diet publication-title: Nature doi: 10.1038/nature05354 – volume: 11 start-page: 206 year: 2010 ident: CR20 article-title: A 3 day EGCG supplementation reduced lactate in skeletal muscle in overweight subjects publication-title: Obes Rev – volume: 25 start-page: 597 year: 2008 end-page: 605 ident: CR9 article-title: Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study publication-title: Diabet Med doi: 10.1111/j.1464-5491.2008.02417.x – volume: 96 start-page: 301 year: 2005 end-page: 307 ident: CR42 article-title: Genistein restricts leptin secretion from rat adipocytes publication-title: J Steroid Biochem Mol Biol doi: 10.1016/j.jsbmb.2005.04.033 – volume: 62 start-page: 1186 year: 2012 end-page: 1195 ident: CR25 article-title: High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition publication-title: Diabetes doi: 10.2337/db12-0975 – volume: 73 start-page: 434 year: 2009 end-page: 436 ident: CR44 article-title: (-)-Epigallocatechin-3-gallate enhances uncoupling protein 2 gene expression in 3T3-L1 adipocytes publication-title: Biosci Biotechnol Biochem doi: 10.1271/bbb.80563 – volume: 14 start-page: 612 year: 2011 ident: BFijo2013231_CR12 publication-title: Cell Metab doi: 10.1016/j.cmet.2011.10.002 – volume: 29 start-page: 2102 year: 2006 ident: BFijo2013231_CR53 publication-title: Diabetes Care doi: 10.2337/dc06-0560 – volume: 29 start-page: 615 year: 2005 ident: BFijo2013231_CR37 publication-title: Int J Obes (Lond) doi: 10.1038/sj.ijo.0802926 – volume: 102 start-page: 1187 year: 2009 ident: BFijo2013231_CR17 publication-title: Br J Nutr doi: 10.1017/S0007114509371779 – volume: 7 start-page: 369 year: 2012 ident: BFijo2013231_CR43 publication-title: Genes Nutr doi: 10.1007/s12263-011-0260-8 – volume: 83 start-page: 2064 year: 1997 ident: BFijo2013231_CR27 publication-title: J Appl Physiol doi: 10.1152/jappl.1997.83.6.2064 – volume: 49 start-page: 33 year: 2005 ident: BFijo2013231_CR28 publication-title: Ann Nutr Metab doi: 10.1159/000084175 – volume: 1290 start-page: 83 year: 2013 ident: BFijo2013231_CR51 publication-title: Ann NY Acad Sci doi: 10.1111/nyas.12185 – volume: 10 start-page: 178 year: 2009 ident: BFijo2013231_CR1 publication-title: Obes Rev doi: 10.1111/j.1467-789X.2008.00544.x – volume: 37 start-page: 841 year: 2008 ident: BFijo2013231_CR3 publication-title: Endocrinol Metab Clin North Am doi: 10.1016/j.ecl.2008.09.002 – volume: 4 start-page: 146 year: 2012 ident: BFijo2013231_CR45 publication-title: Aging (Albany NY) doi: 10.18632/aging.100445 – volume: 288 start-page: R708 year: 2005 ident: BFijo2013231_CR38 publication-title: Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.00693.2004 – volume: 127 start-page: 1109 year: 2006 ident: BFijo2013231_CR11 publication-title: Cell doi: 10.1016/j.cell.2006.11.013 – volume: 8 start-page: e51648 year: 2013 ident: BFijo2013231_CR7 publication-title: PLoS One doi: 10.1371/journal.pone.0051648 – volume: 87 start-page: 778 year: 2008 ident: BFijo2013231_CR19 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/87.3.778 – volume: 67 start-page: 471 year: 2012 ident: BFijo2013231_CR35 publication-title: J Physiol Biochem doi: 10.1007/s13105-011-0086-2 – volume: 11 start-page: 206 year: 2010 ident: BFijo2013231_CR20 publication-title: Obes Rev – volume: 96 start-page: 301 year: 2005 ident: BFijo2013231_CR42 publication-title: J Steroid Biochem Mol Biol doi: 10.1016/j.jsbmb.2005.04.033 – volume: 81 start-page: 1343 year: 2011 ident: BFijo2013231_CR36 publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2011.03.012 – volume: 16 start-page: 120 year: 2012 ident: BFijo2013231_CR32 publication-title: J Med Food doi: 10.1089/jmf.2012.0062 – volume: 64 start-page: 704 year: 2010 ident: BFijo2013231_CR15 publication-title: Eur J Clin Nutr doi: 10.1038/ejcn.2010.47 – volume: 32 start-page: 617 year: 2012 ident: BFijo2013231_CR24 publication-title: Nutr Res doi: 10.1016/j.nutres.2012.06.002 – volume: 344 start-page: 1343 year: 2001 ident: BFijo2013231_CR8 publication-title: N Engl J Med doi: 10.1056/NEJM200105033441801 – volume: 96 start-page: 494 year: 2011 ident: BFijo2013231_CR6 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2010-0822 – volume: 94 start-page: 206 year: 2008 ident: BFijo2013231_CR2 publication-title: Physiol Behav doi: 10.1016/j.physbeh.2007.10.010 – volume: 25 start-page: 597 year: 2008 ident: BFijo2013231_CR9 publication-title: Diabet Med doi: 10.1111/j.1464-5491.2008.02417.x – volume: 26 start-page: 389S year: 2007 ident: BFijo2013231_CR13 publication-title: J Am Coll Nutr doi: 10.1080/07315724.2007.10719627 – volume: 70 start-page: 1040 year: 1999 ident: BFijo2013231_CR14 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/70.6.1040 – volume: 94 start-page: 432 year: 2005 ident: BFijo2013231_CR16 publication-title: Br J Nutr doi: 10.1079/BJN20051502 – volume: 62 start-page: 1186 year: 2012 ident: BFijo2013231_CR25 publication-title: Diabetes doi: 10.2337/db12-0975 – volume: 95 start-page: 5435 year: 2010 ident: BFijo2013231_CR46 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2010-0702 – volume: 97 start-page: 474 year: 2012 ident: BFijo2013231_CR48 publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2012.02.029 – volume: 19 start-page: 298 year: 2010 ident: BFijo2013231_CR18 publication-title: Obesity (Silver Spring) doi: 10.1038/oby.2010.181 – volume: 91 start-page: 1462 year: 2006 ident: BFijo2013231_CR5 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-1598 – volume: 1 start-page: 278 year: 2009 ident: BFijo2013231_CR21 publication-title: J Diabetes doi: 10.1111/j.1753-0407.2009.00045.x – volume: 1290 start-page: 74 year: 2013 ident: BFijo2013231_CR52 publication-title: Ann NY Acad Sci doi: 10.1111/nyas.12141 – volume: 75 start-page: 265 year: 2000 ident: BFijo2013231_CR49 publication-title: J Steroid Biochem Mol Biol doi: 10.1016/S0960-0760(00)00172-2 – volume: 15 start-page: 611 year: 2012 ident: BFijo2013231_CR23 publication-title: Climacteric doi: 10.3109/13697137.2011.631062 – volume: 73 start-page: 434 year: 2009 ident: BFijo2013231_CR44 publication-title: Biosci Biotechnol Biochem doi: 10.1271/bbb.80563 – volume: 444 start-page: 337 year: 2006 ident: BFijo2013231_CR10 publication-title: Nature doi: 10.1038/nature05354 – volume: 137 start-page: 2668 year: 2007 ident: BFijo2013231_CR26 publication-title: J Nutr doi: 10.1093/jn/137.12.2668 – volume: 12 start-page: 155 year: 2008 ident: BFijo2013231_CR40 publication-title: Korean J Physiol Pharmacol doi: 10.4196/kjpp.2008.12.4.155 – volume: 23 start-page: 192 year: 2011 ident: BFijo2013231_CR39 publication-title: Am J Hypertens doi: 10.1038/ajh.2009.228 – volume: 115 start-page: 1467 year: 2007 ident: BFijo2013231_CR22 publication-title: Environ Health Perspect doi: 10.1289/ehp.10413 – volume: 16 start-page: 658 year: 2012 ident: BFijo2013231_CR34 publication-title: Cell Metab doi: 10.1016/j.cmet.2012.09.015 – volume: 87 start-page: 2391 year: 2002 ident: BFijo2013231_CR41 publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem.87.5.8628 – volume: 50 start-page: 2548 year: 2001 ident: BFijo2013231_CR4 publication-title: Diabetes doi: 10.2337/diabetes.50.11.2548 – volume: 59 start-page: 2117 year: 2010 ident: BFijo2013231_CR50 publication-title: Diabetes doi: 10.2337/db10-0519 – volume: 94 start-page: 1026 year: 2005 ident: BFijo2013231_CR33 publication-title: Br J Nutr doi: 10.1079/BJN20051580 – volume: 109 start-page: 1 year: 1949 ident: BFijo2013231_CR30 publication-title: J Physiol doi: 10.1113/jphysiol.1949.sp004363 – volume: 61 start-page: 424 year: 2011 ident: BFijo2013231_CR47 publication-title: Metabolism doi: 10.1016/j.metabol.2011.08.003 – volume: 12 start-page: 410 year: 2005 ident: BFijo2013231_CR29 publication-title: Phytomedicine doi: 10.1016/j.phymed.2004.07.001 – volume: 55 start-page: 628 year: 1983 ident: BFijo2013231_CR31 publication-title: J Appl Physiol doi: 10.1152/jappl.1983.55.2.628 – reference: 16351782 - Br J Nutr. 2005 Dec;94(6):1026-34 – reference: 21106709 - J Clin Endocrinol Metab. 2011 Feb;96(2):494-503 – reference: 21945106 - Metabolism. 2012 Mar;61(3):424-33 – reference: 19445822 - Br J Nutr. 2009 Oct;102(8):1187-94 – reference: 20843950 - J Clin Endocrinol Metab. 2010 Dec;95(12):5435-42 – reference: 18326618 - Am J Clin Nutr. 2008 Mar;87(3):778-84 – reference: 16008116 - Phytomedicine. 2005 Jun;12(6-7):410-5 – reference: 22935345 - Nutr Res. 2012 Aug;32(8):617-25 – reference: 16936160 - Diabetes Care. 2006 Sep;29(9):2102-7 – reference: 18029481 - J Nutr. 2007 Dec;137(12):2668-73 – reference: 17112576 - Cell. 2006 Dec 15;127(6):1109-22 – reference: 19202275 - Biosci Biotechnol Biochem. 2009 Feb;73(2):434-6 – reference: 17938737 - Environ Health Perspect. 2007 Oct;115(10):1467-73 – reference: 22191384 - Climacteric. 2012 Dec;15(6):611-20 – reference: 16449343 - J Clin Endocrinol Metab. 2006 Apr;91(4):1462-9 – reference: - Int J Obes (Lond). 2014 May;38(5):752 – reference: 23193181 - Diabetes. 2013 Apr;62(4):1186-95 – reference: 22436213 - Aging (Albany NY). 2012 Mar;4(3):146-58 – reference: 23418416 - PLoS One. 2013;8(2):e51648 – reference: 10584049 - Am J Clin Nutr. 1999 Dec;70(6):1040-5 – reference: 15394301 - J Physiol. 1949 Aug;109(1-2):1-9 – reference: 19207879 - Obes Rev. 2009 Mar;10(2):178-93 – reference: 9390982 - J Appl Physiol (1985). 1997 Dec;83(6):2064-72 – reference: 20725062 - Obesity (Silver Spring). 2011 Feb;19(2):298-304 – reference: 21455758 - J Physiol Biochem. 2011 Sep;67(3):471-7 – reference: 11282281 - J Steroid Biochem Mol Biol. 2000 Dec 31;75(4-5):265-71 – reference: 19967050 - Korean J Physiol Pharmacol. 2008 Aug;12(4):155-64 – reference: 15735366 - Ann Nutr Metab. 2005 Jan-Feb;49(1):33-41 – reference: 15738931 - Int J Obes (Lond). 2005 Jun;29(6):615-23 – reference: 11994393 - J Clin Endocrinol Metab. 2002 May;87(5):2391-4 – reference: 11333990 - N Engl J Med. 2001 May 3;344(18):1343-50 – reference: 23102619 - Cell Metab. 2012 Nov 7;16(5):658-64 – reference: 11679433 - Diabetes. 2001 Nov;50(11):2548-54 – reference: 18037457 - Physiol Behav. 2008 May 23;94(2):206-18 – reference: 22139637 - Genes Nutr. 2012 Jul;7(3):369-86 – reference: 17086191 - Nature. 2006 Nov 16;444(7117):337-42 – reference: 19026935 - Endocrinol Metab Clin North Am. 2008 Dec;37(4):841-56 – reference: 18445174 - Diabet Med. 2008 May;25(5):597-605 – reference: 19942861 - Am J Hypertens. 2010 Feb;23 (2):192-6 – reference: 17906192 - J Am Coll Nutr. 2007 Aug;26(4):389S-395S – reference: 23855469 - Ann N Y Acad Sci. 2013 Jul;1290:83-9 – reference: 20372175 - Eur J Clin Nutr. 2010 Jul;64(7):704-13 – reference: 21439945 - Biochem Pharmacol. 2011 Jun 1;81(11):1343-51 – reference: 23140132 - J Med Food. 2013 Feb;16(2):120-7 – reference: 6618956 - J Appl Physiol Respir Environ Exerc Physiol. 1983 Aug;55(2):628-34 – reference: 23855468 - Ann N Y Acad Sci. 2013 Jul;1290:74-82 – reference: 20573749 - Diabetes. 2010 Sep;59(9):2117-25 – reference: 16176615 - Br J Nutr. 2005 Sep;94(3):432-6 – reference: 22055504 - Cell Metab. 2011 Nov 2;14 (5):612-22 – reference: 20923528 - J Diabetes. 2009 Dec;1(4):278-87 – reference: 22497970 - Diabetes Res Clin Pract. 2012 Sep;97(3):474-82 – reference: 15970440 - J Steroid Biochem Mol Biol. 2005 Aug;96(3-4):301-7 – reference: 15563575 - Am J Physiol Regul Integr Comp Physiol. 2005 Mar;288(3):R708-15 |
SSID | ssj0005502 ssj0033214 |
Score | 2.368965 |
Snippet | Background and Objectives:
Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent... Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that... BACKGROUND AND OBJECTIVES: Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent... International Journal of Obesity (2014) 38, 698-706; doi:10.1038/ijo.2013.231 Background and Objectives:Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent... Background and Objectives: Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent... |
SourceID | proquest gale pubmed pascalfrancis crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 698 |
SubjectTerms | 631/443/319 692/699/2743/393 692/700/459/1994 Adult Antioxidants - therapeutic use Bioenergetics Biological and medical sciences Body fat Body Mass Index Body size Body weight Calorimetry Catechin - analogs & derivatives Catechin - therapeutic use Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Dietary Supplements Double-Blind Method Double-blind studies Drug Therapy, Combination Energy Energy expenditure Energy metabolism Energy Metabolism - drug effects Epidemiology Fasting Fatty acids Female Flexibility Glucose Glycerol Health aspects Health Promotion and Disease Prevention Humans Insulin resistance Internal Medicine Isoflavones Lifestyles Lipid Metabolism - drug effects Lipid peroxidation Lipids Male Medical sciences Medicine Medicine & Public Health Metabolic Diseases Metabolism Metabolites Middle Aged Mitochondria Musculoskeletal system Obesity original-article Overweight Overweight - diet therapy Overweight - metabolism Overweight persons Oxidation Oxidation-Reduction Physiological aspects Physiological research Polyphenols Polyphenols - therapeutic use Postprandial Period Public Health Quotients Respiratory quotient Resveratrol Stilbenes - therapeutic use Substrates Toxicology Treatment Outcome Womens health |
Title | Short-term supplementation with a specific combination of dietary polyphenols increases energy expenditure and alters substrate metabolism in overweight subjects |
URI | https://link.springer.com/article/10.1038/ijo.2013.231 https://www.ncbi.nlm.nih.gov/pubmed/24317366 https://www.proquest.com/docview/1520967002 https://www.proquest.com/docview/2639125352 https://www.proquest.com/docview/1521913107 https://www.proquest.com/docview/1837323808 |
Volume | 38 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgkxDShKB8BUYxEowHlK2x8-E8oTE2TUirEDCpb5HtOKIoS7q6fdifw3_KneO0VJS9VJV8iR37fP6d74uQt1KUKpV5EjLQcsI44yrMZWlCpvJKi0Ro7TLwXYzT88v4yySZ-As3690qe5noBHXZarwjP4rQXwNjStjH2XWIVaPQuupLaNwlu5i6DF26skm2dvFIRqtcUhwr8vRZEeHUT7wX_IiLo-kvDAOM-CHj0cb55KX03kxamLGqK3WxDYv-Y0d1x9PZQ_LA40p63DHCI3LHNAMSfJ6aBT2gPvlnTcd97v0BuXfhreoDMlhjRyB2dc_tY_L7-0_4E6LophZrf3Z-5o4Kb2-ppBimia5GFKYQNOyura1oCd3K-Q2dtfUN-pC1taXTBvuwxlLjwg0p1hZAe_lybqhsSurs9ha6Ui6Vr6FX8BLV1lN7BQ_T1nlw41UCkuDtkX1CLs9Of5ych76gQ6iTOF2EXAsTVVEuozip4Hw0uVQAR2TES5OOjGYq4ZIb5mDZSMq4YqzSPAYlVecqV_wp2WnaxjwnVImUMwW6pZCgQAqjYuVSGWbAW4plJiAf-mUstM92jkU36sJZ3bkoYNELXPQCFj0g71bUsy7Lx3_oXiNHFF2M6ko4FMc8FSIWSR4H5L2jQPEA_Wnpoxxg1Jhoa4Nyf4MStrXeaB5ucN1qXAwNxcDN8HzPhoWXO7ZY75KtzQzwKCBaAN0BebNqxp7R1a4x7dK9AnR4QP3ZLTSCZxzA3kgE5Fm3A9bjQ0jK0zQgB_2W-Gt8Wyb1xe0f8pLcB8q4czLdJzuL-dK8AiC4UEO32-FXnERDsvvpdPz12x9I_V37 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9Mw8DQ6CZAQgvIVGJuR2HhAYY2dpM4DQoNt6thWIdikvQU7cURRl5SmFerP4Q_wG7lzkpaKsre9VfLZ5_TO5zvfF8BLJVMdqihwOVo5rt8V2o1UalyuoyyRgUwSW4HvtB_2zv2PF8HFGvxucmEorLKRiVZQp0VCb-S7HsVrUE4Jfzf64VLXKPKuNi00KrY4NrOfaLKVb4_2kb7bnB8enH3ouXVXATcJ_HDiikQaL_Mi5flBhkLaRErjnag8kZqwYxKuA6GE4VY36CjlZ5xnifDRUkoiHWmB696AdV-gKdOC9fcH_U-fF0ElQWdevUpQD6CmDiOuFdRx9x0hdwffKfHQE2-48JZuxPpeuDNSJdIoq5prrNJ-__Hc2gvx8B7crTVZtlex3n1YM3kbnP2BmbAdVpcbHbJ-U-2_DTdPaz9-G9oLbRWBbaf18gH8-vINf7h0WbCSuo1Wke0Wit6LmWKUGErBTQyJhjZ9NVZkLEW0ajxjo2I4o6i1YliyQU44SlMyYxMcGXUzIA_9dGyYylNmIwVKRKVt8WDDLnERXQwH5SVOZoWNGafHCwKh96ryIZxfC7EfQSsvcvMEmJah4BqtWanQZJVG-9oWT-wiN2veNQ68bsgYJ3V9dWrzMYytn1_IGIkeE9FjJLoD23PoUVVX5D9wW8QRcZUVOxdH8Z4IpfRlEPkOvLIQJJAQX6LqvArcNZX2WoLcWIJEQZIsDW8ucd18X5xc08jNOL9hw7iWdGW8OJcrhzlqwKhDo5rvwIv5MGGm4L7cFFO7hBd5aGd0r4CRoitQvexIBx5XJ2CxP1KCRRg6sNMcib_2t-JPfXr1h2zBrd7Z6Ul8ctQ_fga3cZZfhbhuQGsynprnqIZO9GZ99hl8vW5x8wf-_5kz |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkCYkhKB8BcZmJDYeUGhj58N5QGiiVBtjFRJM2luwHUcUdUmpW6H-Ofwb_HXcOUlLRdnb3ir5_JHe-Xxn_-6OkBdS5CqWaeQz8HL8MOHKT2VufKbSQotIaO0y8J0N4-Pz8MNFdLFFfrexMAirbHWiU9R5pfGOvBsgXgNjSli3aGARn_qDt5MfPlaQwpfWtpxGLSKnZvET3Df75qQPvD5gbPD-y7tjv6kw4OsojGc-18IERZDKIIwKUNgmlQrORxnw3MQ9o5mKuOSGOTuhJ2VYMFZoHoLXpFOVKg7j3iA3Ex4FuMeSi2QFL4l6yzxWHKsBtRkZYaSoQeD3uOiOvmMIYsBfMx6snY3NCXF7Ii1wq6jLbGyyg_95w3VH4-AuudPYtPSoFsJ7ZMuUHeL1R2ZGD2mTeHRMh23e_w7ZOWte9Duks7JbgdjVXLf3ya_P3-CHj8cGtVh3tMa4Oyq8OaaSYogowpwosA-8-7qtKmgO08rpgk6q8QLxa9XY0lGJc1hjqXGhjhTrGuBb_XxqqCxz6jADFqZSLo2woZcwiKrGI3sJnWnl0ON4jYEkeHNlH5Dza2H1Q7JdVqV5TKgSMWcK_FohwXkVRoXKpVFMQK4VS4xHXrVszHSTaR0Lfowz9-LPRQZMz5DpGTDdIwdL6kmdYeQ_dPsoEVkdH7tUTNkRj4UIRZSGHnnpKFA1wXxaNhEWsGpM8rVGubtGCSpFrzXvrUndcl0MH6lBmqF_K4ZZo_NsttqhG5sZ2MJgTYPB75Hny2acGWF-panmboggDcDjSK6gETzhYGj2hEce1TtgtT40h3kce-Sw3RJ_rW_Dn_rk6g_ZJzugZLKPJ8PTp-QWdAprrOsu2Z5N5-YZ2KMztec2PiVfr1vT_AFt3pwD |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Short-term+supplementation+with+a+specific+combination+of+dietary+polyphenols+increases+energy+expenditure+and+alters+substrate+metabolism+in+overweight+subjects&rft.jtitle=International+Journal+of+Obesity&rft.au=Most%2C+J&rft.au=Goossens%2C+G+H&rft.au=Jocken%2C+J+W+E&rft.au=Blaak%2C+E+E&rft.date=2014-05-01&rft.issn=0307-0565&rft.volume=38&rft.issue=5&rft.spage=698&rft.epage=706&rft_id=info:doi/10.1038%2Fijo.2013.231&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0307-0565&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0307-0565&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0307-0565&client=summon |